Ray Dalio is having a good year with Bridgewater’s flagship fund gaining more than 30% so far

Ray Dalio is having a good year with Bridgewater’s flagship fund gaining more than 30% so far




Source

U.S. and Iran haven’t backed ceasefire idea as Trump’s Hormuz Strait deadline nears
World

U.S. and Iran haven’t backed ceasefire idea as Trump’s Hormuz Strait deadline nears

US President Donald Trump disembarks from Air Force One upon arrival at Joint Base Andrews in Maryland, March 23, 2026. Saul Loeb | Afp | Getty Images President Donald Trump has not backed an idea for a 45-day ceasefire that would take effect before his upcoming deadline for Iran to either reopen the Strait of […]

Read More
S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates
World

S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates

Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on April 2, 2026. Charly Triballeau | Afp | Getty Images The S&P 500 rose on Monday following a winning week as oil prices pulled back, with traders weighing the odds that the U.S.-Iran war could […]

Read More
Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More